Skip to main content
editorial
. 2013 Mar;8(1):59–67.

Table 2.

Cardiovascular manifestations of different classes of chemotherapeutical drugs (modified from 3).

Chemoterapeutical drug Cardiovascular manifestations
Anthracyclines LVD, HF, myocarditis, arrhythmia
5-fluorourcil Ischemia, HF, pericarditis, cardiogenic shock
Taxanes (paclitaxel), vinca alkaloids Sinus bradicardia, ventricular tachycardia, atrioventricular block, HF, ischemia
Cyclophosphamide HF (neurohumoral activation), mitral regurgitation
Trastuzumab HF, LVD, arrhythmia
Tamoxifen Thromboembolism, cholesterol metabolism anomalies
Bevacizumab Hypertension, thromboembolism
COX-2 specific inhibitors Thromboembolism

LVD: left ventricular dysfunction; HF: heart failure